Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy
Read more about
Publication category: Cancer Immunotherapy
Distinct Cellular and Molecular Patterns in Pretreatment Peripheral Blood Are Associated with CAR T-cell Outcomes in Diffuse Large B-cell Lymphoma
Read more about
Publication category: Cancer Immunotherapy
ZEB2 is a master switch controlling the tumor-associated macrophage program
Read more about
Publication category: Cancer Immunotherapy
